Harvard Gene Therapy Initiative Provides plasmid construction and virus production services for gene therapy in both research and Category Science Biology Animal Mammal Human gene therapygene therapy Initiative, Harvard Institute of Human Genetics, HarvardMedical School, Children's Hospital, Boston. Conducts research http://hgti.med.harvard.edu/
Gene Therapy For The Bald Forget the Hair Club for Men. gene therapy may someday help bald men to grow new hair. Scientists graft tiny bits of human scalp to mice in an effort to develop a method of delivery of genetic material to hair follicles. Wired News http://www.wired.com/news/news/story/20142.html
Extractions: FDA Talk Papers are prepared by the Press Office to guide FDA personnel in responding with consistency and accuracy to questions from the public on subjects of current interest. Talk Papers are subject to change as more information becomes available. Media Inquiries: 301-827-6242 January 14, 2003 Consumer Inquiries: 888-INFO-FDA FDA PLACES TEMPORARY HALT ON GENE THERAPY TRIALS In a precautionary measure, the Food and Drug Administration (FDA) today placed on "clinical hold" all active gene therapy trials using retroviral vectors to insert genes into blood stem cells. FDA took this action after it learned that a second child treated in a French gene therapy trial has developed a leukemia-like condition. Both this child, and another who had developed a similar condition last August, had been successfully treated by gene therapy for X-linked severe combined immunodeficiency disease (X-SCID), also known as "bubble baby syndrome." Infants with X-SCID have a gene defect that leads to a complete lack of white blood cells that can fight infection. Without treatment, they die from complications of infectious diseases during the first year of life. The only treatment for this condition is a bone marrow transplant.
Coming Soon! Develops new methods and applications of human gene therapy for cancer prevention, treatment and cure; Category Science Biology Animal Mammal Human gene therapyThe site you requested is currently unavaliable. It will be functioning shortly,so check back often! Go back, or return to Spindustry Systems, Inc. http://www.hgtri.org/
CBER - Cellular & Gene Therapy The Center for Biologics Evaluation and Research (CBER) regulates human gene therapyproducts products that introduce genetic material into the body to http://www.fda.gov/cber/gene.htm
Extractions: Blood Therapeutics Vaccines Allergenics ... About Us The Center for Biologics Evaluation and Research (CBER) regulates human gene therapy products - products that introduce genetic material into the body to replace faulty or missing genetic material, thus treating or curing a disease or abnormal medical condition. CBER uses both the Public Health Service Act and the Federal Food Drug and Cosmetic Act as enabling statutes for oversight. FDA has not yet approved any human gene therapy product for sale. However, the amount of gene-related research and development occurring in the United States continues to grow at a fast rate and FDA is actively involved in overseeing this activity. FDA has received many requests from medical researchers and manufacturers to study gene therapy and to develop gene therapy products. Such research could lead to gene-based treatments for cancer, cystic fibrosis, heart disease, hemophilia, wounds, infectious diseases such as AIDS, and graft-versus-host disease. Last Updated: 1/24/2003 The Sixth US-Japan Cellular and Gene Therapy Conference - 2/20/2003 Cloning Technology
IHGT - Institute For Human Gene Therapy Institute for Human gene therapy, University of Pennsylvania. Providing a foundation for basic research necessary to assure the success of human gene therapy. Main page. http://www.med.upenn.edu/~ihgt/
FINNISH GENE THERAPY SOCIETY - MAIN PAGE gene therapy has matured as an exciting new field of research which will havea significant impact on biology and medicine during the next decade. http://www.uku.fi/fgts/
Extractions: MESSAGE FROM THE PRESIDENT Dear Friends, Gene therapy has matured as an exciting new field of research which will have a significant impact on biology and medicine during the next decade. Both pathogenesis of various diseases and basic biological pathways can be studied by gene transfer techniques. Thus, gene transfer will provide a versatile tool for researchers to solve emerging biological questions. However, it is also evident that systematic basic research is needed to improve gene transfer vectors and delivery methods before the full potential of gene transfer techniques can be realized. Finnish scientists have been active in the field of gene therapy for several years. Since the number of researchers engaged in gene transfer and gene therapy studies has steadily increased, it was felt that it is time to establish Finnish Gene Therapy Society. The major aims of the Society are to foster the exchange of ideas between research groups and individual scientists, to organize scientific meetings and training courses and to inform general public about basic aspects and recent developments of gene therapy. Finnish Gene Therapy Society will also establish a Fund for travel grants for promising young scientists. We plan to maintain an updated www home page in order to improve exchange of ideas and information in the field of gene therapy. I am looking forward to working with you to create a very active and stimulating Society. I also welcome all comments and suggestions regarding future activities of the Society.
Extractions: May-June 1999 Gene Therapy Investigators have been searching for ways to add corrective genes to cells harboring defective genes. A better strategy might be to correct the defects. Most of the gene therapy techniques developed so far are of the gene-addition variety; that is, they attempt to provide a good copy of a gene to a cell that harbors a bad one. The hope is that the good, corrective gene will compensate for the bad one and restore the cell to its proper function. Gene addition has been achieved by a variety of means not only in test-tube experiments, but in clinical trials involving real patients as well. Yet, to date, the results of these trials have been disappointing. Even the most successful clinical trial has fallen short of therapeutic efficacy. Unfortunately, many of these trials have been widely publicized and, in some cases, oversold in popular books and magazine articles. Having failed to live up to the inflated expectations created by such publicity, these disappointing trial results have left a general impression that gene therapy cannot now or ever fulfill its initial promise. But these clinical trials may have been conducted before the technology was fully mature, driven in part by investor demands on biotechnology companies to rush products to market. Such clinical trials were almost certainly destined to fall short of the mark.
Archport Ltd. Home Page Bio-Pharmaceutical Contract Manufacturing Provides contract production and R D services (including animal cell fermentation and downstream processing) to the biopharmaceutical/biotechnology industry, of recombinant proteins. Indepth information on suspension, microcarriers, perfusion, batch fermentation, and gene therapy applications. http://www.archport.ie
American Scientist: Gene Therapy MayJune, 1999 Volume 87, No. 3 gene therapy. Investigators have been searchingfor ways to add corrective genes to cells harboring defective genes. http://www.sigmaxi.org/amsci/articles/99articles/Kmiec.html
Extractions: Eric B. Kmiec It has been the hope of biomedical researchers to find ways to fix the genes that cause disease. Over a decade ago, when researchers at MIT realized that viruses could be modified to carry corrective genes into cells, gene therapy seemed to be an eventuality. But to date, no one has found a way to reliably control the therapeutic genes to make them clinically useful. Our author surveys the history of this field and gives us a peek at the future of gene therapy, where the emphasis may be less on replacing defective genes and more on correcting them. Sigma Xi About Us Latest Issue Bookshelf ... Web Admin
Cancer Gene Therapy Publishes original laboratory and clinical research papers, case reports and review articles covering developments in gene transfer and gene therapy as applied to cancer research. Full articles available by subscription . http://www.naturesj.com/cgt/
Extractions: nature.com about npg nature science update naturejobs ... help SEARCH my account e-alerts subscribe register ... Journal home For readers Content Online sample issue E-alerts Indexed in ... Society publishing NPG Subject areas Access material from all our publications in your subject area: Biotechnology Cancer Chemistry Clinical Medicine ... Physics
TKT - Transkaryotic Therapies Develops and commercializes gene activation and nonviral gene therapy products for long term treatment of a broad range of human diseases. (Nasdaq TKTX). http://www.tktx.com/
Extractions: In one of the first treatments of its kind, UK doctors have used gene therapy to cure a toddler of a potentially fatal disorder. Scientists at Great Ormond Street Hospital in London successfully treated 18-month-old Rhys Evans, who had a condition preventing him from developing an immune system. The problem, called severe combined immunodeficiency (SCID) is caused by a single mutated gene, and meant that he had to live in sterile conditions or risk picking up a life-threatening infection.
University Of Texas M. D. Anderson Cancer Center Gene Therapy Department The human cancer gene prevention and therapy program conducts basic research, clinical trials and Category Science Biology Animal Mammal Human gene therapyWelcome to the WM Keck Center for Cancer gene therapy website. Genetherapy is the transfer of normal or redesigned genes into a http://www.mdanderson.org/depts/genetherapy/
Extractions: Message from the Program Directors Program Members Institutional Vector Core What's New ... Gene Therapy Links Development Awards Welcome to the W.M. Keck Center for Cancer Gene Therapy website. Gene therapy is the transfer of normal or redesigned genes into a patient to reduce or alleviate a disease state. Certain potentially cancerous genes are dormant in all of us and are sometimes triggered into activity. Other genes, tumor-suppressor genes, act naturally to stop unregulated growth of cancer cells. Please browse this site to learn more about the Keck Center. Message from the Program Directors The gene therapy program at the University of Texas M.D. Anderson Cancer Center has assembled over 50 scientists and clinicians with an interest in sharing research ideas and findings worldwide. We all share the common goal of curing cancer Membership If you are Interested in joining the W.M. Keck Center for Cancer Therapy, please forward Debbie Waits a current copy of your CV and your research interests in gene therapy. Ms. Waits' e-mail address is firstname.lastname@example.org.
MEDLINEplus: Genes And Gene Therapy Search MEDLINE for recent research articles on Genes and gene therapy gene therapy Gene mapping. More News on Genes and gene therapy. http://www.nlm.nih.gov/medlineplus/genesandgenetherapy.html
Extractions: Latest News Two Genes Found Key in Parkinson's Risk in Women (03/20/2003, Reuters Health) Obesity Found to Have Many, Varied Causes (03/20/2003, United Press International) Some Cases of Obesity Caused by a Single Gene (03/19/2003, Reuters Health) FDA Advisory Committee Discusses Steps for Potentially Continuing Certain Gene Therapy Trials That Were Recently Placed on Hold (02/28/2003, Food and Drug Administration) FDA Places Temporary Halt on Gene Therapy Trials Using Retroviral Vectors in Blood Stem Cells (01/14/2003, Food and Drug Administration) More News on Genes and Gene Therapy From the National Institutes of Health Frequently Asked Questions About Genetics (National Human Genome Research Institute) Human Genome Project (National Human Genome Research Institute) Questions and Answers About Gene Therapy (National Cancer Institute) General/Overviews
Another Chance For Gene Therapy? An 18year-old man has died after undergoing experimental gene therapy for a rare metabolic disease. Researchers say it shouldn't stigmatize all gene therapy. By Kristen Philipkoski. Wired News http://www.wired.com/news/news/story/22036.html
Extractions: David M. Sander, Ph.D. (email@example.com ) If you are interested in developing a WWW site for your lab or organization, please feel free to contact me for any needed advice and/or assistance. Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy - Dr. Harold Varmus, Director, National Institutes of Health (NIH), appointed an ad hoc committee to assess the current status and promise of gene therapy and provide recommendations regarding future NIH-sponsored research in this area. The Panel was asked specifically to comment on how funds and efforts should be distributed among various research areas and whatfunding mechanisms would be most effective in meeting research goals. Biotechnology and Gene Therapy Web 'Cite' - a large index of Gene Therapy information on the net.
Vanderbilt Radiation Oncology Research at a hightechnology treatment facility clinical trials; biological modifiers; therapeutic targets; industry validation of efficacy of pharmaceutical, imaging and radiotherapy methods; medical physics of radiotherapy delivery; radiation-guided drug delivery and gene therapy imaging. Regional facilities. http://www.mc.vanderbilt.edu/radiationoncology
Extractions: The mission of the Department of Radiation Oncology is to improve the treatment outcomes of all diseases treated with radiation and to find new medical uses of radiation. Related to these goals are the education of graduate students, post-doctoral students and residents who will enter the field of radiation medicine including the allied fields of Medical Physics and Radiation Therapy. The Department of Radiation Oncology provides state-of-the-art anti-cancer therapy for patients through the use of new technology and through the continuous review of patient treatment outcome. We will continue to evaluate and improve the therapeutic effects of radiation from five fronts: 1) Basic science research to indentify new biological modifiers and therapeutic targets.
Extractions: Please note: Words in italics are the official PIBS affiliations of the indicated faculty. James R. Baker Jr., MD Determining why autoantigens are recognized in autoimmune disease; epitope mapping thyroid autoantigens from patients with autoimmune thyroid disease. Immunology. Pathology. Kate F. Barald, Ph.D. Developmental neurobiology; molecular neurobiology studies of developing neuronal cells and synapses; gene expression in the neural crest; molecular studies of inner ear development. Cell and Developmental Biology. Neuroscience. Cellular and Molecular Biology. D. Keith Bishop, Ph.D. Cellular immunology of transplant rejection and acceptance. Microbiology and Immunology. Immunology. Sally A. Camper, Ph.D. Developmental genetics of the neuroendocrine system; transgenic mice; gene targeting; pituitary dwarfism. Human Genetics. Bioinformatics. Cellular and Molecular Biology. Neuroscience. Michael F. Clarke, MD